Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Med Robot ; 20(1): e2615, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38536714

ABSTRACT

BACKGROUND: In Total Hip replacement (THR) surgery, a critical step is to cut an accurate hemisphere into the acetabulum so that the component can be fitted accurately and obtain early stability. This study aims to determine whether burring rather than reaming the acetabulum can achieve greater accuracy in the creation of this hemisphere. METHODS: A preliminary robotic system was developed to demonstrate the feasibility of burring the acetabulum using the Universal Robot (UR10). The study will describe mechanical design, robot trajectory optimisation, control algorithm development, and results from phantom experiments compared with both robotic reaming and conventional reaming. The system was also tested in a cadaver experiment. RESULTS: The proposed robotic burring system can produce a surface in 2 min with an average error of 0.1 and 0.18 mm, when cutting polyurethane bone block #15 and #30, respectively. The performance was better than robotic reaming and conventional hand reaming. CONCLUSION: The proposed robotic burring system outperformed robotic and conventional reaming methods to produce an accurate acetabular cavity. The findings show the potential usage of a robotic-assisted burring in THR for acetabular preparation.


Subject(s)
Arthroplasty, Replacement, Hip , Hip Prosthesis , Robotic Surgical Procedures , Robotics , Humans , Acetabulum/surgery , Arthroplasty, Replacement, Hip/methods
2.
Intern Med J ; 47(4): 458-461, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28401718

ABSTRACT

This study investigated the cost implications of poor compliance to established guidelines for management of suspected pulmonary embolism (PE) in two NSW public hospitals. A retrospective audit showed that the prevalence of PE overall was 9.9% (4.3% in the low-risk groups) in 436 patients. An estimated total of $32 454 (14%) was spent on unnecessary tests.


Subject(s)
Clinical Audit , Critical Pathways/organization & administration , Pulmonary Embolism/economics , Pulmonary Embolism/therapy , Angiography , Cost-Benefit Analysis , Decision Support Techniques , Female , Fibrin Fibrinogen Degradation Products , Humans , Male , New South Wales , Pulmonary Embolism/diagnosis , Retrospective Studies , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL